RHKd logo

RHÖN-KLINIKUM BATS-CHIXE:RHKd Stock Report

Last Price

€10.15

Market Cap

€743.0m

7D

0%

1Y

n/a

Updated

20 Mar, 2024

Data

Company Financials

RHÖN-KLINIKUM Aktiengesellschaft

BATS-CHIXE:RHKd Stock Report

Market Cap: €743.0m

RHKd Stock Overview

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany.

RHKd fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance4/6
Financial Health4/6
Dividends1/6

RHÖN-KLINIKUM Aktiengesellschaft Competitors

Price History & Performance

Summary of all time highs, changes and price drops for RHÖN-KLINIKUM
Historical stock prices
Current Share Price€10.15
52 Week High€0
52 Week Low€0
Beta-0.014
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Change-59.63%
Change since IPO-52.19%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

RHKdGB HealthcareGB Market
7D0%1.0%0.7%
1Yn/a-29.6%3.0%

Return vs Industry: Insufficient data to determine how RHKd performed against the UK Healthcare industry.

Return vs Market: Insufficient data to determine how RHKd performed against the UK Market.

Price Volatility

Is RHKd's price volatile compared to industry and market?
RHKd volatility
RHKd Average Weekly Movementn/a
Healthcare Industry Average Movement7.5%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.4%
10% least volatile stocks in GB Market2.7%

Stable Share Price: RHKd has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine RHKd's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
197318,158Tobias Kaltenbachwww.rhoen-klinikum-ag.com

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

RHÖN-KLINIKUM Aktiengesellschaft Fundamentals Summary

How do RHÖN-KLINIKUM's earnings and revenue compare to its market cap?
RHKd fundamental statistics
Market cap€743.02m
Earnings (TTM)€31.92m
Revenue (TTM)€1.71b

23.3x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RHKd income statement (TTM)
Revenue€1.71b
Cost of Revenue€1.50b
Gross Profit€202.27m
Other Expenses€170.35m
Earnings€31.92m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Mar 28, 2024

Earnings per share (EPS)0.48
Gross Margin11.85%
Net Profit Margin1.87%
Debt/Equity Ratio11.9%

How did RHKd perform over the long term?

See historical performance and comparison

Dividends

1.4%

Current Dividend Yield

31%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.